Scientists describe potential antibody approach for treating multidrug-resistant Klebsiella pneumoniae

Researchers are developing a promising alternative to antibiotic treatment for infections caused by Klebsiella pneumoniae bacteria resistant to carbapenem antibiotics.

Klebsiella bacteria. Image credit: NIAID

The approach uses antibodies to target the K. pneumoniae protective capsule polysaccharide, allowing immune system cells called neutrophils to attack and kill the bacteria.

The early stage, in vitro research was conducted by scientists at the National Institute of Allergy and Infectious Diseases’ (NIAID) Rocky Mountain Laboratories and the New Jersey Medical School-Rutgers University.

A carbapenem-resistant K. pneumoniae strain known as multilocus sequence type 258 (ST258) is one of the antibiotic-resistant organisms labeled an urgent threat by the Centers for Disease Control and Prevention.

ST258 is particularly concerning because it is resistant to most antibiotics. It is a significant cause of mortality among people with bloodstream infections.

The researchers first determined that the bacterial capsule prevents immune system neutrophils from ingesting and killing ST258. They then extracted capsule from the two most abundant capsule types of ST258 and used them to generate antibodies in rabbits.

In cell culture experiments they found that one of the antibodies enhanced the ability of neutrophils to ingest and kill bacteria. These results are a “proof of concept” for a potential immunotherapy approach for treatment of multidrug-resistant K. pneumoniae infections, the authors write.

Next up, the researchers will test the therapeutic concept in mice. They also will compare immunization with purified capsule polysaccharide as a preventive approach (active immunization) versus using capsule-specific antibodies as a therapy (passive immunization).

Ultimately, they hope either antibody treatment alone or in combination with antibiotics could greatly improve care for people with multidrug-resistant K. pneumoniae infections. (National Institutes of Health)

YOU MAY ALSO LIKE

Experiments recreate aromatic flavors of Titan

NASA scientists have created a new recipe that captures key flavors of the brownish-orange atmosphere around Saturn’s largest moon, Titan.

Driverless Bus-train Hybrid Runs on Virtual Painted Tracks

A Chinese company has unveiled a driverless bus-train hybrid that uses white lines painted on the road to navigate.

Giant Bubbles on Red Giant Star’s Surface

Astronomers using ESO’s Very Large Telescope have for the first time directly observed granulation patterns on the surface of a star outside the Solar System — the ageing red giant π1 Gruis.

Warming due to carbon dioxide jumped by half in 25 years

Human activity has increased the direct warming effect of carbon dioxide in the atmosphere by 50 percent above pre-industrial levels during the past 25 years, according to NOAA's 10th Annual Greenhouse Gas Index.

Air pollution exposure in early pregnancy linked to miscarriage

Exposure to common air pollutants, such as ozone and fine particles, may increase the risk of early pregnancy loss.

World's forests increasingly taking up more carbon

The world's forests are increasingly taking up more carbon, partially offsetting the carbon being released by the burning of fossil fuels and by deforestation in the tropics.